ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

シタロプラム·臭化水素塩

Citalopram Hydrobromide

HCID 77995
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
59729-32-7
標準SMILES
Br.CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
InChIKey
WIHMBLDNRMIGDW-UHFFFAOYSA-N
分子式
C20H22BrFN2O
平均分子量
405.3 g/mol
単同位体質量
404.08995

概要

Citalopram Hydrobromide is the orally bioavailable hydrobromide salt of the racemic bicyclic phthalene derivative citalopram with antidepressant activity. As a selective serotonin reuptake inhibitor (SSRI), citalopram selectively inhibits the CNS neuronal reuptake of serotonin, thereby potentiating serotonergic activity in the central nervous system (CNS). This agent has minimal effects on the CNS neuronal reuptake of norepinephrine (NE) and dopamine (DA).

名称と識別子

優先名称
Citalopram Hydrobromide
IUPAC
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide
現地名
シタロプラム·臭化水素塩
英語名
Citalopram hydrobromide
分子式
C20H22BrFN2O
分子量
405.3

名称と別名

citalopram hydrobromide59729-32-7Citalopram HBrElopramSeropramLu 10-171-BCitalopram (as hydrobromide)PaxoranPerrigo citalopramNSC-758684I1E9D14F36LU-10-171-B
名称をさらに表示
シタロプラム臭化水素酸塩シタロプラム·臭化水素塩1-[3-(ジメチルアミノ)プロピル]-1-(4-フルオロフェニル)-1,3-ジヒドロ-5-イソベンゾフランカルボニトリル·臭化水素酸塩シタロプラム·臭化水素酸塩1-[3-(ジメチルアミノ)プロピル]-1-(4-フルオロフェニル)-1,3-ジヒドロイソベンゾフラン-5-カルボニトリル臭化水素酸塩シタロプラム, 臭化水素酸塩シタロプラム 臭化水素酸塩シタロプラム 臭化水素酸塩 溶液ERDOSTEINCitalopram hydrogen bromideCitalopram for system suitability CRSBonitrile HBrLu 10-171 HBrCitalopran HBrCitalopram-D4BrCitalopraM HBr APICitalopram HBr Salt
DTXSID408723441-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile monohydrobromide5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, monohydrobromideRefChem:548341-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile monohydrobromide3-(5-cyano-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-1-yl)-N,N-dimethylpropan-1-aminium bromideCHEBI:3724DTXCID60819993

物性

構造計算による物性補完中

極性表面積
36.3 Ų
水素結合供与体数
1
水素結合受容体数
4
回転可能結合数
5
重原子数
25
形式電荷
0
複雑度
466

実験および物理化学的性質

Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

物理化学的性質

融点
182 · 182-188°C
闪点
9 ℃ · 9℃
貯蔵温度
2 · 2-8°C
溶解性
2 O: · H2O: 可溶 (控えめに)
外見
粉
色
白い
水溶解度
50 mM · Soluble to 50 mM in ethanol and to 10 mM in water
Merck
14 · 14,2318
安定性
安定。強力な酸化剤とは相容れない。
主な用途
臨床検査
InChI
1S/C20H21FN2O.BrH/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20;/h4-9,12H,3,10-11,14H2,1-2H3;1H
InChIKey
WIHMBLDNRMIGDW-UHFFFAOYSA-N
SMILES
Br.CN(C)CCCC1(OCc2cc(ccc12)C#N)c3ccc(F)cc3
CAS データベース
59729 · 59729-32-7(CAS DataBase Reference)

化学的性質

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (96.5%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P273, P301+P317, P330, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 115 reports by companies from 15 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory InformationCitalopram hydrobromide: Does not have an individual approval but may be used under an appropriate group standard
Hazard Classes and CategoriesAcute Tox. 4 (96.5%)

毒性情報

Treatment · 1 件

Establish and maintain an airway to ensure adequate ventilation and oxygenation. Gastric evacuation by lavage and use of activated charcoal should be considered. Careful observation and cardiac and vital sign monitoring are recommended, along with general symptomatic and supportive care. Due to the large volume of distribution of citalopram, forced diuresis, dialysis, hemoperfusion, and exchange transfusion are unlikely to be of benefit. There are no specific antidotes for Celexa. (L1712)

Exposure RoutesRapidly and well absorbed from the GI tract. Peak plasma concentrations occur within 4 hours of a single orally administered dose. Bioavailability is 80% following oral administration. Food does not affect absorption.
Toxicity Summary · 1 件

The antidepressant, antiobsessive-compulsive, and antibulimic actions of citalopram are presumed to be linked to its inhibition of CNS neuronal uptake of serotonin. Citalopram blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane, enhancing the actions of serotonin on 5HT<sub>1A</sub> autoreceptors. SSRIs bind with significantly less affinity to histamine, acetylcholine, and norepinephrine receptors than tricyclic antidepressant drugs.

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Citalopram is metabolized mainly in the liver via <i>N</i>-demethylation to its principle metabolite, demethylcitalopram. Other metabolites include didemethylcitalopram, citalopram <i>N</i>-oxide, and a deaminated propionic acid derivative. However, the predominant entity in plasma is unchanged citalopram. Cytochrome P450 (CYP) 3A4 and 2C19 isozymes appear to be principally involved in producing demethylcitalopram. Demethylcitalopram appears to be further <i>N</i>-demethylated by CYP2D6 to didemethylcitalopram. Citalopram metabolites possess little pharmacologic activity in comparison to their parent compound and do not likely contribute to the clinical effect of the drug. Route of Elimination: 12-23% of an oral dose of citalopram is recovered unchanged in the urine, while 10% of the dose is recovered in the feces. Half Life: 35 hours

FDA Pharmacological Classification · 2 件

CITALOPRAM HYDROBROMIDE

Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]

MeSH Pharmacological Classification · 2 件

A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.

Compounds that specifically inhibit the reuptake of serotonin in the brain.

用途と製造

Uses · 1 件

For the treatment of depression. Unlabeled indications include: treatment of mild dementia-associated agitation in nonpsychotic patients, smoking cessation, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy.

応用分野 · 5 件

用途選択的セロトニン取り込み阻 害剤(SSRI)です。

選択的セロトニン取り込み阻 害剤(SSRI)です。

関連反応

23 件
反応記録を作成
HRID 489491 の反応式
HRID 489491生成物として
HRID 496867 の反応式
HRID 496867生成物として
HRID 526806 の反応式
HRID 526806反応物として
HRID 526807 の反応式
HRID 526807反応物として
HRID 526808 の反応式
HRID 526808反応物として
HRID 526809 の反応式
HRID 526809反応物として
HRID 526810 の反応式
HRID 526810反応物として
HRID 840347 の反応式
HRID 840347生成物として
前へ1 / 3 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
59729-32-7
PubChem CID
77995
DTXSID
DTXSID40872344
ChEMBL
CHEMBL1200781
UNII
I1E9D14F36
EC Number
261-890-6

化学的特性White or almost white, crystalline powder.

Signs and Symptoms · 1 件

Symptoms most often accompanying citalopram overdose, alone or in combination with other drugs and/or alcohol, included dizziness, sweating, nausea, vomiting, tremor, somnolence, and sinus tachycardia. In more rare cases, observed symptoms included amnesia, confusion, coma, convulsions, hyperventilation, cyanosis, rhabdomyolysis, and ECG changes (including QTc prolongation, nodal rhythm, ventricular arrhythmia, and very rare cases of torsade de pointes). Acute renal failure has been very rarely reported accompanying overdose. Withdrawal symptoms include flu-like symptoms, insomnia, nausea, imbalance, sensory changes and hyperactivity.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Citalopram hydrobromide

vLess-DILI-concern

7

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

安全データ

wgk
3
rtecs
NP6313500
ridadr
3249
hs_code
29329990
risk_code
11-23/24/25-39/23/24/25-22
hazard_code
F,T
safety_code
7-16-36/37-45-24/25
hazard_class
6.1(b)
packing_group
III
毒劇物取締法
劇物
Hazard Classifications
Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralFlam. Liq. 2STOT SE 1
ストレージクラス
3 - Flammable liquids
用途

説明Citalopram (hydrobromide) (Item No. 23252) is an analytical reference material categorized as an antidepressant. This product is intended for use in analytical forensic applications. This product is also available as a general research tool .

使用Citalopram hydrobromide has been used:to examine its effects onsirtmRNA and mammalian sirtuins (SIRT) expression in miceto monitor body temperature and antidepressant-like behavioral responses in the forced swim test for ratsfor 5-hydroxytryptamine (5-HT) competition uptake assays

一般的な説明Citalopram is an antidepressant sold under the trade names Celexa and Cipramil for the treatment of major depression. Citalopram is a selective serotonin reuptake inhibitor, a class of drugs that also includes fluoxetine, paroxetine, and sertraline. This Certified Snap-N-Spike Solution is suitable for use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis, urine drug testing, or pharmaceutical research.

上流・下流製品情報

上流原料

ブチルリチウム硝酸マグネシウム·6水和物塩化スルフィニルイソプロピルマグネシウムクロリド (11%テトラヒドロフラン溶液, 約1mol/L)炭素ジオンtert-ブチルメチルエーテルスルファミドo-キシリレン オキシド